Many “cures” are problematic and unsustainable
A new paper claims that induced stem cells are functionally equivalent to embryonic stem cells
Australian Researchers have managed to grow a mini-kidney in a laboratory
Whatever happened to the mad cloners?
Regulators in the United States and Australia are examining the burgeoning field of stem cell therapies.
Shades of Hwang Woo-suk.
A noble goal, but there are too many unanswered questions.
A Portuguese stem-cell trial gone wrong has resulted in a woman developing a nasal growth on her back.
Nature has retracted a paper and a letter, both published in January, which claimed that physical perturbation of cells could create genetic effects.
Haruko Obokata reportedly has told co-authors on the paper on stimulus-triggered acquisition of pluripotency (STAP) cells that she was prepared to retract it.
The Icarus-like rise of Japanese stem cell research Haruko Obokata has ended with a gigantic splash.
The case of Davide Vannoni, head of the stem cell therapy company Stamina Foundation, is turning into an election issue.
The Japanese woman at the centre of the latest stem cell scandal, Haruko Obokata, has apologised tearfully for her “carelessness, ignorance and immaturity”.
Once again, a promising method comes unstuck after allegations of scientific misconduct.
How could a 30-year-old junior researcher at a leading institute report incredible results in the world’s leading science journal despite dubious data?
The latest development comes with a bundle of ethical problems.
Stem cells are stem cells, says an expert. They are not and cannot be embryos.
The world’s leading science journal, Nature, may end up with egg on its face as complaints mount about a recent paper on a radical new method of creating pluripotent stem cells.
Doubt cast on daring claims by cardiologist
Page 1 of 5 : 1 2 3 > Last ›